Citigroup initiated coverage on Kiniksa Pharmaceuticals with a new price target

3/13/25 7:43:42 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Citigroup initiated coverage of Kiniksa Pharmaceuticals with a rating of Buy and set a new price target of $40.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$KNSA

Date	Price Target	Rating	Analyst
3/13/2025	$40.00	Buy	Citigroup
9/13/2024	$40.00	Buy	Jefferies
5/3/2024	$34.00	Overweight	Wells Fargo
12/29/2021	$37.00 → $34.00	Buy	B of A Securities